Join our email list!

Get daily updates delivered to your inbox
Thank you for subscribing

Articles You Can’t Miss Before ACTRIMS 2016


2. Ocrelizumab: Could Genentech/Roche’s Experimental Drug Be the First Effective Progressive MS Therapy?


One of the topics which will be presented are the results from Ocrelizumab (the same drug that got lots of attention at ECTRIMS in Barcelona last year).

Learn more about it here:

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *